Default Category
-
Measuring Impairment at Dofasco
Mary Gillett; Mary-Jane MastrandreaCase IVEY-9B09B017-EAccounting and ControlIn December 2008, the ArcelorMittal Dofasco (Dofasco) accounting team was facing a significant challenge. In the past few years, Dofasco had undergone significant ownership changes, and when the firm had first been acquired the market had placed a premium share value on the Dofasco subsidiary. In light of a recent economic downturn, the accounting team was required to reassess the values assigned to the subsidiary's net assets. Dismal forecasted ...Starting at €8.20
-
McGill St Laurent: Growing a Commodities Trading Firm
Jesse Prent; Gwyneth Edwards; Raymond L. PaquinCase IVEY-9B20M116-EEntrepreneurship, StrategyIn May 2018, Philippe Boisclair, business owner and president of McGill St Laurent (MSL), sought to grow the firm and increase annual profitability by CA$35 million by 2020. MSL was a medium-sized commodities trading firm with interests in wood, grain, and energy. Founded in 2009 by two business school graduates and veterans of the lumber industry, MSL had enjoyed significant growth. The company had not only expanded into grain and energy trading...Starting at €8.20
-
Technologies Ecofixe: Green Wastewater Treatment for Africa
Roxanne Lavoie-Drapeau; Gwyneth EdwardsCase IVEY-9B20M079-EEntrepreneurship, StrategyIn September 2018, Marisol Labrecque, president of Technologies Ecofixe Inc. (Technologies Ecofixe), was heading to Ain Taoujdate, Morocco, in order to supervise the installation of the company’s second ECOFIXE system in Africa. Technologies Ecofixe was aStarting at €8.20
-
Accounting at Biovail - Revised
Mary Gillett; Mary-Jane Mastrandrea; Jessica FrischCase IVEY-9B09B004-EAccounting and ControlBiovail was a large international pharmaceutical company with reported revenues of $788 million. Banc of America has issued a research report which indicates that Biovail Corporation's financial statements raised a number of issues that warrant caution for investors, and as a result, Biovail's stock was given a sell rating by Banc of America. A member of Biovail's audit committee is preparing for an upcoming audit meeting and considers the implic...Starting at €8.20